1.   Because it is considered so novel, gene therapy trials are regulated not only by FDA but by the Recombinant DNA Advisory Committee of the National Institutes of Health.

2.   Beth Israel Deaconess Medical Center has suspended its remaining human gene therapy trial, citing growing concerns about the safety of the procedure.

3.   A National Institutes of Health advisory committee will meet in Washington, D.C., tomorrow to look into the reported instances of deaths during gene therapy trials.

4.   Companies conducting gene therapy trials are therefore required to monitor where in the body the new genes are being inserted.

5.   Companies conducting gene therapy trials are thus required to monitor where in the body the new genes are inserted.

6.   Dave Frohnmayer has a more compelling reason than most to be watching the new gene therapy trial under way in Seattle.

7.   Ethical considerations required them to choose terminally ill volunteers for the first gene therapy trials.

8.   However, until now, the FDA rules permit companies to withhold details of gene therapy trials because they are considered commercially important trade secrets.

9.   If the gene therapy trial against the blood disease leukocyte adherence deficiency proves successful, scientists may move quickly to test the same techniques against Fanconi anemia.

10.   If the therapy proves to be the cause, it will be apparently the first treatment-related death in a gene therapy trial.